Cathelicidin and Its Role in Metabolic Syndrome and Inflammation
Author Information
Author(s): Popa Alina Delia, Gherasim Andreea, Caba Lavinia, Niță Otilia, Graur Mariana, Mihalache Laura, Arhire Lidia Iuliana
Primary Institution: University of Medicine and Pharmacy “Grigore T. Popa”
Hypothesis
What is the impact of cathelicidin on metabolic syndrome and chronic inflammation?
Conclusion
Cathelicidin is crucial in balancing inflammatory and anti-inflammatory responses in metabolic syndrome.
Supporting Evidence
- Cathelicidin is linked to inflammation in adipose tissue and insulin resistance in obesity.
- LL-37 levels negatively correlate with HDL cholesterol.
- Cathelicidin may aggravate cardiovascular complications associated with metabolic syndrome.
Takeaway
Cathelicidin helps our body fight inflammation and can affect how we process fats and sugars, which is important for people with metabolic syndrome.
Methodology
This is a narrative review analyzing literature on cathelicidin's relationship with metabolic syndrome.
Limitations
The review does not present new experimental data and relies on existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website